Artrya (ASX:AYA) Buildings And Improvements : A$0.00 Mil (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Artrya Buildings And Improvements?

Artrya Buildings And Improvements Historical Data

The historical data trend for Artrya's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Artrya Buildings And Improvements Chart

Artrya Annual Data

Trend

Jun21

Jun22

Jun23

Jun24

Buildings And Improvements

Artrya Semi-Annual Data
	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Buildings And Improvements	Get a 7-Day Free Trial			-	-	-	-	-

Artrya Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction. Broker and architect fees, permits, etc. can be covered within this category. Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized. Improvements are commonly recorded at acquisition cost. Building improvement examples include roofing, remodeling, replacements, etc.

Artrya Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Artrya Ltd (ASX:AYA) » Definitions » Buildings And Improvements

Comparable Companies

Traded in Other Exchanges

N/A

Address

1257 Hay Street, West Perth, Perth, WA, AUS, 6005

Website

https://www.artrya.com

Artrya Ltd is a medical technology company. It is engaged in the development and commercialization of Artrya Salix, its patented artificial intelligence platform that detects, diagnoses, and helps address coronary artery disease. The company is managed based on a single segment, being the development of AI-driven CCTA image analysis technology.

Artrya Headlines

No Headlines